Log In
Print
BCIQ
Print
Print this Print this
 

MKC204

  Manage Alerts
Collapse Summary General Information
Company MannKind Corp.
DescriptionEndoplasmic reticulum to nucleus signaling 1 (ERN1; IRE1) alpha inhibitor
Molecular Target Endoplasmic reticulum to nucleus signaling 1 (ERN1) (IRE1)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationMultiple myeloma (MM)
Indication DetailsTreat multiple myeloma (MM)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today